amubarvimab (BRII-196) - Brii Biosci
Evusheld (cilgavimab/tixagevimab) - AstraZeneca
romlusevimab (BRII-198) - Brii Biosci
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
remdesivir - Generic mfg.
ensovibep (MP0420) - AGC Biologics, Molecular Partners, Novartis
http://www.ncbi.nlm.nih.gov/pubmed/39922466
 
; Adit Ginde; Ahmad Mourad; Alfredo J Mena Lora; Barnaby Edward Young; Cavan Reilly; Christina Barkauskas; D Ashley Price; Daniel B Knox; David Vock; Eleftherios Mylonakis; Elizabeth Higgs; Gail Mathews; Gregory A Grandits; Jakob J Malin; Jens Lundgren; John C Williamson; Jonathan Kitonsa; Kami Kim; Lianne K Siegel; Mamta Jain; Nicole Engen; Nnakelu Eriobu; Roger Paredes; Srikanth Ramachandruni; Thomas A Murray; Thomas L Holland; Tomas O Jensen; Uriel Sandkovsky; Vasiliki Rapti; Wesley H Self
 
Feb 9, 2025
 
Prev Next